Serum-mediated suppression of nonspecific B-cell activation. III. Selective inhibition of the polyclonal B-cell response by normal mouse serum
- PMID: 3496164
- DOI: 10.1016/0008-8749(87)90250-4
Serum-mediated suppression of nonspecific B-cell activation. III. Selective inhibition of the polyclonal B-cell response by normal mouse serum
Abstract
Normal, nonimmune adult serum is known to inhibit in vitro immune responses when present in sufficient amounts. The significance of inhibition of the immune response by serum, however, is not known. Previous work suggested that normal mouse plasma or serum (NMS) was selectively more inhibitory to nonantigen-specific (e.g., polyclonal) as compared to antigen-specific responses. This led to the hypothesis that constituents of serum (or plasma) may serve naturally to minimize the polyclonal type of antibody response, preserving immune specificity. The present study further examined the effect of NMS on polyclonal versus antigen-specific antibody responses. Under the in vitro assay conditions used, 0.5% NMS supported bacterial endotoxin (ET)-induced mitogenic and polyclonal B lymphocyte responses, antigen (SRBC, TNP-KLH)-specific antibody (IgM, IgG) responses, and antigen-induced or -specific T-lymphocyte proliferative responses, while 5% NMS inhibited all of these responses. However, antigen-specific T-lymphocyte responses could be restored by a 10-fold increase in the antigen concentration and antigen-specific antibody responses could be restored by the addition of ET (10 micrograms/ml) as adjuvant. On the other hand, the mitogenic response to ET remained suppressed regardless of ET concentration. Thus, despite significant reduction of the mitogenic and polyclonal properties of ET in 5% NMS (greater than 70% suppression), sufficient antigenic stimuli permitted optimal specific T- and B-cell responses. Many naturally occurring antigens, e.g., bacterial, fungal, and viral, have inherent B-cell mitogenic and polyclonal activity in addition to adjuvanticity and the presence of the serum inhibitory factor may serve to minimize their indiscriminate polyclonal stimulation of antibody.
Similar articles
-
Serum-mediated suppression of nonspecific B cell activation. I. Description of an inhibitory capacity in normal mouse serum and characterization of the inhibitory component.J Immunol. 1981 May;126(5):1852-56. J Immunol. 1981. PMID: 6163819
-
Serum-mediated suppression of nonspecific B cell activation. II. Relative resistance of B cells from the NZB mouse strain to regulation by a natural inhibitor in normal mouse serum.J Immunol. 1981 Sep;127(3):1204-7. J Immunol. 1981. PMID: 6973581
-
Carrier-directed anti-hapten responses by B-cell subsets.J Exp Med. 1977 Jul 1;146(1):1-10. doi: 10.1084/jem.146.1.1. J Exp Med. 1977. PMID: 68986 Free PMC article.
-
Inhibition of B lymphocyte activation by interaction with Fc receptors.Immunol Commun. 1976;5(5):455-68. doi: 10.3109/08820137609033860. Immunol Commun. 1976. PMID: 786867 Review.
-
A two-phase model of B-cell activation.Immunol Rev. 2000 Aug;176:171-80. doi: 10.1034/j.1600-065x.2000.00606.x. Immunol Rev. 2000. PMID: 11043776 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources